352 related articles for article (PubMed ID: 18926645)
1. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
Rush CR; Stoops WW; Hays LR
Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
[TBL] [Abstract][Full Text] [Related]
2. Cocaine choice in humans during D-amphetamine maintenance.
Rush CR; Stoops WW; Sevak RJ; Hays LR
J Clin Psychopharmacol; 2010 Apr; 30(2):152-9. PubMed ID: 20520288
[TBL] [Abstract][Full Text] [Related]
3. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.
Stoops WW; Blackburn JW; Hudson DA; Hays LR; Rush CR
Drug Alcohol Depend; 2008 Jan; 92(1-3):282-5. PubMed ID: 17719727
[TBL] [Abstract][Full Text] [Related]
5. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
[TBL] [Abstract][Full Text] [Related]
6. Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.
Bolin BL; Stoops WW; Sites JP; Rush CR
J Addict Med; 2016; 10(3):156-65. PubMed ID: 26933876
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys.
Czoty PW; Martelle JL; Nader MA
Psychopharmacology (Berl); 2010 May; 209(4):375-82. PubMed ID: 20217052
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of intranasal cocaine during phendimetrazine maintenance.
Stoops WW; Strickland JC; Hays LR; Rayapati AO; Lile JA; Rush CR
Psychopharmacology (Berl); 2016 Jun; 233(11):2055-2063. PubMed ID: 26932737
[TBL] [Abstract][Full Text] [Related]
9. Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.
Greenwald MK; Lundahl LH; Steinmiller CL
Neuropsychopharmacology; 2010 Dec; 35(13):2624-37. PubMed ID: 20881947
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2003 May; 167(3):324-32. PubMed ID: 12652348
[TBL] [Abstract][Full Text] [Related]
11. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status.
Stoops WW; Lile JA; Robbins CG; Martin CA; Rush CR; Kelly TH
Addict Behav; 2007 Jun; 32(6):1177-88. PubMed ID: 17011712
[TBL] [Abstract][Full Text] [Related]
12. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
Stoops WW; Vansickel AR; Lile JA; Rush CR
Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine self-administration in humans during D-amphetamine maintenance.
Pike E; Stoops WW; Hays LR; Glaser PE; Rush CR
J Clin Psychopharmacol; 2014 Dec; 34(6):675-81. PubMed ID: 25154010
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
[TBL] [Abstract][Full Text] [Related]
16. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
Stoops WW; Lile JA; Lofwall MR; Rush CR
Am J Drug Alcohol Abuse; 2007; 33(6):769-76. PubMed ID: 17994473
[TBL] [Abstract][Full Text] [Related]
17. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
Stoops WW; Lile JA; Glaser PE; Rush CR
Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
Blanken P; Nuijten M; van den Brink W; Hendriks VM
Addiction; 2020 May; 115(5):917-923. PubMed ID: 31908066
[TBL] [Abstract][Full Text] [Related]
19. Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse.
Jasinski DR; Krishnan S
J Psychopharmacol; 2009 Jun; 23(4):419-27. PubMed ID: 19329547
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
Stoops WW
Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
